EYA4 Antibodies

Santa Cruz Biotechnology offers a broad range of EYA4 monoclonal antibodies for research focused on understanding EYA4 protein functions. EYA4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EYA4, a member of the EYA family of proteins, plays a critical role in developmental processes and cellular signaling pathways. EYA4 is involved in the regulation of gene expression and has been implicated in various biological functions, including cell differentiation and proliferation. Research has shown that EYA4 may have significant implications in developmental disorders and cancer. Understanding EYA4's molecular mechanisms and interactions can provide valuable insights into disease progression and potential therapeutic targets. Investigating EYA4's expression patterns and regulatory functions helps advance knowledge in developmental biology and oncology. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of EYA4's role in health and disease.